  See all
 |
Articles: Leukemia/Lymphoma |
Prior Articles
Clinical relevance of vascular endothelial growth factor (VEGFA) and VEGF receptor (VEGFR2) gene polymorphism on the treatment outcome following imatinib therapy
Annals of Oncology, 11/04/09
Overcoming resistance in chronic myelogenous leukemia
Leukemia and Lymphoma, 11/04/09 Quantitative PCR analysis for BcL-2/IgH in a phase III study of Yttrium-90 ibritumomab tiuxetan as consolidation of first remission in patients with follicular lymphoma
Journal of Clinical Oncology, 11/03/09 Age-specific differences in oncogenic pathway dysregulation and anthracycline sensitivity in patients with acute myeloid leukemia
Journal of Clinical Oncology, 11/03/09 Identification of Key Regions and Genes Important in the Pathogenesis of Sezary Syndrome by Combining Genomic and Expression Microarrays
Cancer Research, 11/03/09 The impact of prophylactic fresh frozen plasma and cryoprecipitate on the incidence of CNS thrombosis and hemorrhage in children with acute lymphoblastic leukemia receiving asparaginase
Blood, 11/02/09 A gene expression signature of CD34+ cells to predict major cytogenetic response in chronic phase chronic myeloid leukemia patients treated with imatinib
Blood, 11/02/09 An impaired transendothelial migration potential of chronic lymphocytic leukemia cells can be linked to ephrin-A4 expression
Blood, 11/02/09 Chemokine induction by all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia - triggering the differentiation syndrome
Blood, 11/02/09 T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics and outcome from the large randomised prospective trial (UKALL XII/ECOG 2993)
Blood, 11/02/09 Enhanced Leukemia Cell Detection Using a Novel Magnetic Needle and Nanoparticles
Cancer Research, 11/02/09 Outcomes for lymphoid malignancies in the Nurses Health Study (NHS) as compared to the Surveillance, Epidemiology and End Results (SEER) Program
Hematological Oncology, 11/02/09 Characterization of a rituximab variant with potent antitumor activity against rituximab-resistant B-cell lymphoma
Blood, 11/02/09 Targeted therapy in T-cell malignancies: dysregulation of the cellular signaling pathways
Leukemia, 11/02/09 Management of T-cell and natural-killer-cell neoplasms in Asia: consensus statement from the Asian Oncology Summit 2009
The Lancet Oncology, 11/02/09 The Novel Tubulin-Targeting Agent Pyrrolo-1,5-Benzoxazepine-15 Induces Apoptosis in Poor Prognostic Subgroups of Chronic Lymphocytic Leukemia
Cancer Research, 11/02/09 Nilotinib for the frontline treatment of Ph+ chronic myeloid leukemia
Blood, 10/30/09 MACOP-B regimen in the treatment of adult Langerhans cell histiocytosis: experience on seven patients
Annals of Oncology, 10/30/09 Clinical outcome in patients with small intestinal non-Hodgkin lymphoma
Leukemia and Lymphoma, 10/30/09 Patients with del(5q) MDS who fail to achieve sustained erythroid or cytogenetic remission after treatment with lenalidomide have an increased risk for clonal evolution and AML progression
Annals of Hematology, 10/30/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology
more...
|
250 Available Pages
|
|
